We and others have shown (Patel et al., 1998; Lee et al., 1999; Tutt et al., 1999) that the genome‐wide DNA damage that follows homozygous inactivation of BRCA2 leads to checkpoint activation and cell cycle arrest, rather than the unrestrained cellular proliferation typical of cancer. The gene discussed is BRCA2; the disease is cancer.